Opportunity Information: Apply for PA 07 158
Apply for PA 07 158
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Early Identification and Treatment of Mental Disorders in Children and Adolescents (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants.
- This funding opportunity was created on Dec 5, 2008 and posted on Dec 13, 2006.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Independent school districts For profit organizations other than small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) County governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Public and State controlled institutions of higher education.
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Early Identification and Treatment of Mental Disorders in Children and Adolescents (R01) opportunity (Funding Opportunity Number PA 07-158) is a National Institute of Mental Health (NIMH) funding announcement under the National Institutes of Health (NIH) that supports investigator-initiated research aimed at improving how mental disorders are recognized and treated earlier in life. The central idea is to push the field toward better detection of mental health conditions in children and teens, including very young children, and to test treatments early enough to reduce symptoms, prevent worsening impairment, and improve long-term developmental and functional outcomes.
Projects responsive to this announcement can cover a wide range of studies, but they generally revolve around two connected goals: earlier identification and better early intervention. On the identification side, NIMH is interested in research that validates early diagnoses in youth and strengthens confidence in how clinicians and researchers define and measure early signs of mental disorders. On the treatment side, the announcement calls for studies that develop new interventions or refine existing ones, evaluate efficacy and safety, and determine how to keep children and adolescents from experiencing escalating functional impairment at home, in school, and in social settings. The FOA also highlights the importance of understanding why treatments work when they do, and why they fail when they do not, encouraging research on predictors of treatment response and underlying mechanisms of action.
A notable emphasis is the expectation that studies can draw on diverse assessment approaches and measurable markers. This can include behavioral assessments and clinical rating scales, neuropsychological testing, neuroimaging methods, and other physiological measures or biomarkers. The point is not that every project must use high-tech measures, but that strong, well-justified measurement strategies are welcome, especially when they help validate early identification methods or clarify how an intervention produces change.
In terms of interventions, NIMH signals openness to multiple treatment modalities and combinations of them. Supported projects may evaluate pharmacological treatments (including medication strategies), psychosocial approaches (such as psychotherapy or family-based interventions), and rehabilitative interventions (such as services designed to improve functioning and skills). Studies can test these approaches independently or in combination, which fits real-world clinical practice where multimodal care is common.
The FOA also explicitly supports work that looks beyond short-term symptom reduction. It encourages research on the long-term effectiveness and downstream impact of early intervention, including how early treatment influences later clinical course as children mature into adolescence and adulthood. In addition, it recognizes that even effective treatments can fall short if families cannot access them or if they are hard to deliver well in routine care. Because of that, the announcement invites studies examining the practical factors that help or hinder access to services, as well as factors in community and practice settings that shape how effective services are for children and adolescents in everyday conditions.
This opportunity uses the NIH Research Project Grant (R01) mechanism, which is typically suited for larger, hypothesis-driven projects with substantial scope. At the same time, NIH notes that related or similar scientific aims may also fit other grant mechanisms, including the R03 (small research grant), R21 (exploratory/developmental grant), and the NIMH R34 (clinical exploratory research grant), each of which is designed for different stages of evidence development, from early feasibility work to more developed clinical research planning.
Funding levels and the number of awards are not specified as fixed amounts because NIH expects applications to vary widely in design, duration, and cost. Award size and project period are therefore determined by the needs of the proposed work and by NIH priorities and available funds, with final outcomes depending on the number, quality, and budgets of applications received.
Eligibility is broad and includes many types of organizations. Eligible applicants include public and private institutions of higher education, nonprofit organizations both with and without 501(c)(3) status, small businesses and other for-profit entities (including those beyond small businesses), state and local governments, US territories and possessions, tribal governments and tribally designated organizations, regional organizations, and other eligible federal agencies. The FOA also makes clear that foreign (non-US) entities are eligible to apply, and that faith-based and community-based organizations may apply as well. The CFDA listing associated with the program is 93.242 (Mental Health Research Grants), and the announcement states there is no cost sharing or matching requirement.
Administratively, the opportunity was posted December 13, 2006, and it uses multiple receipt dates rather than a single deadline, meaning applicants were expected to follow NIH’s standard submission cycles and the specific receipt date schedule referenced in the full announcement. The announcement is archived with an archive date of April 5, 2009, and additional details, including application instructions and policy requirements, are provided through the NIH grants page linked in the original notice.
FAQs: Early Identification and Treatment of Mental Disorders in Children and Adolescents (R01) - PA 07-158
What is this funding opportunity?
This is a National Institute of Mental Health (NIMH) funding announcement under the National Institutes of Health (NIH) titled "Early Identification and Treatment of Mental Disorders in Children and Adolescents (R01)." The Funding Opportunity Number is PA 07-158, and it uses the NIH Research Project Grant (R01) mechanism.
What is the main purpose of PA 07-158?
The purpose is to support investigator-initiated research that improves how mental disorders are recognized earlier in childhood and adolescence (including very young children) and how treatment can be delivered early enough to reduce symptoms, prevent worsening impairment, and improve long-term developmental and functional outcomes.
What kinds of projects are considered responsive to this announcement?
Projects generally align with two connected goals: (1) earlier identification of mental disorders in children and adolescents, and (2) better early intervention. Responsive studies may validate early diagnoses, improve how early signs are defined and measured, develop or refine interventions, evaluate efficacy and safety, and examine how to prevent escalating functional impairment at home, in school, and in social settings.
Is the focus limited to adolescents, or does it include younger children?
The scope includes children and adolescents, and it explicitly notes interest in very young children as well.
Does the FOA prioritize early diagnosis validation?
Yes. On the identification side, NIMH highlights research that validates early diagnoses in youth and strengthens confidence in how clinicians and researchers define and measure early signs of mental disorders.
What is meant by "early intervention" in this FOA?
Early intervention refers to developing new treatments or refining existing ones and testing them early in the course of illness to reduce symptoms, prevent worsening impairment, and improve longer-term developmental and functional outcomes.
What treatment approaches can be studied under this opportunity?
NIMH signals openness to multiple modalities, including pharmacological treatments (medication strategies), psychosocial approaches (such as psychotherapy or family-based interventions), and rehabilitative interventions (services designed to improve functioning and skills). Studies may evaluate these independently or in combination.
Are combination or multimodal interventions allowed?
Yes. The announcement notes that approaches may be tested independently or in combination, consistent with real-world clinical practice where multimodal care is common.
Does the FOA require research on why treatments work (or do not work)?
It encourages it. The FOA emphasizes understanding why treatments succeed or fail by supporting research on predictors of treatment response and underlying mechanisms of action.
What outcomes does NIMH care about besides symptom reduction?
The FOA explicitly encourages research that goes beyond short-term symptom reduction and looks at long-term effectiveness and downstream impact, including how early treatment influences later clinical course as children mature into adolescence and adulthood.
Does this opportunity support studies on functional impairment in daily settings?
Yes. A key aim is to prevent escalating functional impairment, including impairment at home, in school, and in social settings.
What types of assessment methods or measures are encouraged?
The FOA welcomes diverse assessment approaches and measurable markers. Examples mentioned include behavioral assessments and clinical rating scales, neuropsychological testing, neuroimaging methods, and other physiological measures or biomarkers.
Is neuroimaging or biomarker collection required?
No. The point is not that every project must use high-tech measures, but that strong, well-justified measurement strategies are encouraged, especially when they help validate early identification methods or clarify how an intervention produces change.
Does the FOA support research on access to care or real-world implementation factors?
Yes. It recognizes that effective treatments may still fall short if families cannot access them or if they are difficult to deliver well in routine care. The FOA invites studies examining practical factors that help or hinder access to services and factors in community and practice settings that shape effectiveness in everyday conditions.
What grant mechanism is used for this opportunity?
This opportunity uses the NIH Research Project Grant (R01) mechanism, which is generally suited for larger, hypothesis-driven projects with substantial scope.
Are other NIH/NIMH mechanisms mentioned as potentially appropriate for similar aims?
Yes. The announcement notes that related or similar scientific aims may also fit other grant mechanisms, including R03 (small research grant), R21 (exploratory/developmental grant), and the NIMH R34 (clinical exploratory research grant), depending on the stage and needs of the research.
How much funding is available per award?
Funding levels are not specified as fixed amounts. Award size and project period are determined by the needs of the proposed work and by NIH priorities and available funds, with outcomes depending on the number, quality, and budgets of applications received.
Is the number of awards specified?
No. The number of awards is not fixed and depends on the application pool, budgets requested, priorities, and available funds.
Is there a cost sharing or matching requirement?
No. The announcement states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad. Eligible applicants include public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status; small businesses and other for-profit entities; state and local governments; US territories and possessions; tribal governments and tribally designated organizations; regional organizations; other eligible federal agencies; and faith-based and community-based organizations.
Are non-US (foreign) organizations eligible to apply?
Yes. The FOA states that foreign (non-US) entities are eligible to apply.
What is the CFDA number associated with this program?
The CFDA listing associated with the program is 93.242 (Mental Health Research Grants).
When was this opportunity posted, and what is its status?
The opportunity was posted on December 13, 2006. It is archived, with an archive date of April 5, 2009.
Was there a single application deadline?
No. The opportunity used multiple receipt dates rather than a single deadline, meaning applicants were expected to follow NIH standard submission cycles and the specific receipt date schedule referenced in the full announcement.
Where are the official application instructions and policy requirements located?
The announcement indicates that additional details, including application instructions and policy requirements, are provided through the NIH grants page linked in the original notice.
Browse more opportunities from the same category: Health
Next opportunity: Temporomandibular Joint and Muscle Disorders Pathophysiological Mechanisms Linking Comorbid Conditions (R01)
Previous opportunity: Oral Health of Special Needs and Older Populations (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 07 158
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 07 158) also looked into and applied for these:
| Funding Opportunity |
|---|
| Temporomandibular Joint and Muscle Disorders Pathophysiological Mechanisms Linking Comorbid Conditions (R01) Apply for PA 07 150 Funding Number: PA 07 150 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Research on Mental Illnesses in Older Adults (R01) Apply for PA 07 163 Funding Number: PA 07 163 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Psychopathology In Intellectual Disabilities (Mental Retardation) (R01) Apply for PA 07 162 Funding Number: PA 07 162 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epidemiological and Behavioral Research in Oral Health (R01) Apply for PA 07 169 Funding Number: PA 07 169 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Studies of Bisphosphonate Therapy and Osteonecrosis of the Jaws (R01) Apply for PA 07 185 Funding Number: PA 07 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epidemiological Research on Disorders of Hearing, Balance, Smell, Taste, Voice, Speech, and Language (R01) Apply for PA 07 251 Funding Number: PA 07 251 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Proteomics in Auditory Developmental and Disease Processes (R01) Apply for PA 07 252 Funding Number: PA 07 252 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Immunology of Biofilms (R01) Apply for PA 07 288 Funding Number: PA 07 288 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Small Grant Program (R03) Apply for PAR 07 287 Funding Number: PAR 07 287 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Advances in Polycystic Kidney Disease (R01) Apply for PA 07 293 Funding Number: PA 07 293 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Preliminary Investigations Leading To Optimal Trials In Neurology (R01) Apply for PAR 07 294 Funding Number: PAR 07 294 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Hypersensitivity Pneumonitis Early Identification and Mechanisms of Disease (R01) Apply for PA 07 300 Funding Number: PA 07 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mental Health Consequences Of Violence And Trauma (R01) Apply for PA 07 312 Funding Number: PA 07 312 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mental Health Consequences of Violence and Trauma (R03) Apply for PA 07 313 Funding Number: PA 07 313 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Mental Health Consequences Of Violence And Trauma (R34) Apply for PAR 07 315 Funding Number: PAR 07 315 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Mental Health Consequences Of Violence And Trauma (R21) Apply for PA 07 314 Funding Number: PA 07 314 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Stress Management Interventions to Reduce Risk of Coronary Artery Disease (R01) Apply for PA 07 322 Funding Number: PA 07 322 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Hyperglycemic Exacerbation of Ischemia/Reperfusion Injury after Ischemic Insult (R01) Apply for PA 07 323 Funding Number: PA 07 323 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R03) Apply for PA 07 215 Funding Number: PA 07 215 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies on Oral Health Promotion Research across the Life Span (R21) Apply for PA 07 223 Funding Number: PA 07 223 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 158", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
